Author

Donghwa Kim

University of California, San FranciscoORCID 0000-0003-1425-213XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

DongHwa Kim1 paper · University of Pennsylvania

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Beatrice GiniiD· 1 shared Dora Barbosa· 1 shared Hani GoodarziiD· 1 shared Johnny X. YuiD· 1 shared Paul Allegakoen· 1 shared Sarah Elmes· 1 shared Sohit MiglaniiD· 1 shared Trever Grant BivonaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Beatrice GiniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMay 19, 2025

Actionable biological programs to enhance EGFR-targeted therapy response unveiled by single-cell lineage tracing in clinically relevant lung cancer models

Beatrice Gini, Whitney Tamaki, Johnny X. Yu…·Trever Grant Bivona

This study uses single-cell lineage tracing and RNAseq to identify pre-existing resistant tumor subclones in lung cancer models and their transcriptional programs, revealing mechanisms of therapy resistance.

DOI 10.1101/2025.05.19.654081

𝕏 PostBluesky